White House freezes $108m in funds to Duke University over affirmative action
The National Institutes of Health reportedly halted the funding to the private university in North Carolina, said the person who spoke to the Associated Press on Wednesday on the condition of anonymity to discuss internal deliberations. CNN and ABC News also reported the funding freeze.
The development came as, earlier this week, the Department of Health and Human Services and the Department of Education issued a joint letter to Duke, stating that it had been made aware of allegations of what it called racial preferences in Duke's 'hiring, student admissions, governance, patient care, and other operations'.
Duke is the latest institution to have its federal funding held up as the government investigates allegations of antisemitism and policies that support greater diversity, equity and inclusion that the Trump administration alleges are unlawful. It follows other investigations by the administration into top-flight private universities, including the Ivy League's Harvard, Columbia and Cornell.
Duke did not immediately comment on the reported funding freeze.
In Monday's letter to Duke, the Trump administration states that it has been made aware of allegations that Duke University and Duke Health are engaged in practices that, 'if true, would violate Titles VI of the Civil Rights Act and Section 1557 of the Affordable Care Act, and render Duke Health unfit for any further financial relationship with the federal government'.
'These practices allegedly include illegal and wrongful racial preferences and discriminatory activity in recruitment, student admissions, scholarships and financial aid, mentoring and enrichment programs, hiring, promotion, and more,' the letter from the government states.
The letter does not provide any specific examples.
'Racism is a scourge when practiced by individuals, but it is especially corrosive when enshrined in the nation's most eminent and respected institutions,' the letter, signed by the US health secretary, Robert F Kennedy Jr, and the education secretary, Linda McMahon, adds.
The letter orders Duke to end any practices at its health system that give 'benefits or advantages' based on race.
Saying Duke is unlikely to be capable of an 'honest and trustworthy review', the letter takes the unusual step of requesting a new merit and civil rights committee that would be approved by the government and authorized by the school's board of trustees.
The panel would be tasked with identifying and ending any racial preferences. If problems remained after six months, the administration would pursue legal enforcement, the letter said.
The education department separately opened an investigation into the Duke Law Journal on Monday over allegations that it gave advantages to prospective editors from underrepresented groups.
The Trump administration has used federal research funding as leverage in its unprecedented effort to reshape universities that Trump has described as hotbeds of liberalism.
Sign up to This Week in Trumpland
A deep dive into the policies, controversies and oddities surrounding the Trump administration
after newsletter promotion
It has presented a crisis for universities that rely on federal grants as a major source of revenue, spurring some to take on debt and find other ways to self-fund research.
Duke University spent $1.5bn on research last year, with nearly 60% coming from federal sources, according to the university's website.
Even before the latest funding freeze, Duke faced financial turmoil. Last week, university leaders said almost 600 employees had accepted voluntary buyouts but that layoffs would still be needed. Officials said they needed to reduce costs amid uncertainty around federal research funding and a hike to the university's federal endowment tax.
The Trump administration has been ratcheting up pressure on universities in hopes of striking deals such as one that Columbia University signed last week.
The Ivy League school agreed to pay a $200m settlement over three years to the federal government and make changes to admissions, hiring, student discipline and more in exchange for regaining access to federal funding, among other things.
In exchange for Columbia's concessions, the White House will reinstate $400m in federal funding it had stripped from the university earlier this year over allegations that it allowed antisemitism to fester on campus.
The Columbia deal was met with mixed reactions from students, faculty and alumni.
The administration has described it as a template for other universities including Harvard, which has been in talks with the administration even as it battles the White House in court.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
11 minutes ago
- The Independent
FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths
U.S. health regulators are warning doctors and patients about safety issues with two separate Boston Scientific heart devices recently linked to injuries and deaths. The Food and Drug Administration issued two alerts Wednesday about electrical problems tied to the company's heart-zapping defibrillator systems and a separate issue with a heart implant used to reduce stroke risk. The agency said the company's Endotak Reliance defibrillator wires can become calcified, leading to failures in delivering life-saving shocks to the heart, according to the FDA. Defibrillators are surgically placed in the upper chest, where they monitor irregular heartbeats and use electrical shocks to jolt the heart back to normal. As of July 24, Boston Scientific has reported 386 serious injuries and 16 deaths associated with this issue, the agency said. Ten of the deaths were judged to be due to the device failing to function properly, the company said in an email. Four were linked to attempts to surgically remove the devices from patients and two others were deemed unrelated to the implants. Boston Scientific's wires were distributed between 2002 and 2021 and are no longer available, the company noted in its letter to doctors. Some patients will need to have the devices replaced, though physicians should weigh the risks of the removal procedure. In a separate notice, the FDA said Boston Scientific recently updated instructions for implanting its Watchman device, which closes a portion of the heart's left atrium to reduce the risk of stroke. In a letter to physicians, the company noted that there is an increased risk of blockages in the bloodstream depending on the level of anesthesia for patients undergoing the initial implantation procedure. Watchman is an alternative to long-term treatment with blood thinners for patients at increased risk of stroke. As of July 30, the company has reported 120 serious injuries and 17 deaths related to the issue, the FDA said. A company investigation concluded that the safety issue 'is not associated with the design or manufacture of any component of the Watchman system. Heart devices, including defibrillators and other implants, are Boston Scientific's largest business, making up two-thirds of its $5 billion in revenue for the most recent quarter. Shares of Boston Scientific Corp. fell nearly 1.8 percent Wednesday to close at $102.95 in trading. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
The Independent
11 minutes ago
- The Independent
Trump slashed Medicaid — now he's got another health care crisis looming
President Donald Trump and congressional Republicans are trying to sell the American public on their ' One Big, Beautiful Bill ' despite the fact many Americans, and even members in their own conference, worry about the cuts to Medicaid. Most voters do not trust Trump on health care and fear the significant cuts to Medicaid. Republicans already face hostile voters in their town halls when it comes to health care. But as if that were not a big enough problem, Trump and the Republicans face another looming crisis that could cause health care prices to spike. And it comes from an old political enemy: The Affordable Care Act, Barack Obama's signature health care law. 'I think there's going to be a lot of sticker shock of people who aren't following this debate in Congress and are going to be stunned by just how much their rates go up, because the premiums will increase substantially,' Jonathan Oberlander, a professor of social medicine at the University of North Carolina-Chapel Hill, told The Independent. In 2022, then-Senate Majority Leader Chuck Schumer brokered a deal with now former senator Joe Manchin for the Inflation Reduction Act. As part of the agreement, the bill extended an expansion of subsidies to the Affordable Care Act that initially passed under the American Rescue Plan Act, Joe Biden's signature piece of legislation to provide relief during the Covid-19 pandemic. Under the Affordable Care Act, also known as Obamacare, people who might not have health insurance under their employer but are not eligible for Medicaid can purchase health care on state exchanges. If they earn an income below a certain threshold, they could be eligible for tax credits. 'They might not get employer-sponsored health care, but they're like realtors or entrepreneurs or small business owners or Uber drivers,' one former Capitol Hill aide who now works in health care told The Independent. 'These folks – going to the exchanges trying to purchase their health insurance, they're on the precipice of seeing a big cost of living increase.' The subsidies initially passed under the ARPA, and then later under the IRA, increased eligibility for people making up to 400 percent of the Federal Poverty Line. But they expire at the end of the calendar year. Oberlander said it could create a cost crisis. 'It's going to affect people in the sense that the pool will become smaller, and therefore, depending on who leaves, because it depends – the people are leaving healthier or sicker than the average, it can destabilize the pools to some extent.' he said. 'And people are going to read about it and see it, and they're going to feel it and they're going to pay it, and I think there would be a lot of anger.' Sen. Thom Tillis (R-N.C.), who will not seek re-election in 2026, said Republicans could extend the package, specifically in a year-end spending package. 'I've got to believe that that may become a discussion and the year end appropriations, at least some sort of a short term extension, so they can sort it out,' he told The Independent last week before recess. The government runs out of funding for the fiscal year at the end of September. Open enrollment for the health insurance marketplaces typically begins in November. But Democrats are not as confident. 'Here we are trying to fix all the things that they broke,' Sen. Tina Smith (D-Minn.) told The Independent. 'You've got Republican senators introducing bills to undo the things that they just passed.' There's evidence this could have massive consequences for patients. In December 2024, the nonpartisan Congressional Budget Office warned that 2.2 million Americans could lose their health insurance by 2026 if the extended subsidies expired. It also warned that 3.7 million people could lose coverage by 2027. Still, some Republicans said that they do not want to make a fix. 'Obamacare is doing so much damage to our healthcare system, to our federal budget, I don't want to renew any part of it. quite honestly,' Sen. Ron Johnson (R-Wisc.) told The Independent. 'We need to repair the damage done by Obamacare.' But Trump might not have a choice. Polling shows that health care is one of the few policies where voters still trust Democrats more than Republicans. 'This is not the same ACA that he ran against in 2016, it covers many more people, both through Medicaid and in the marketplace,' Oberlander said. 'It's much more popular than it was, and if his administration and congressional Republicans are seen as gutting the health insurance marketplaces and raising people's millions of people's premiums, that's bad politics, and it's bad politics at a time when he already has a fairly low approval rating.'
The Independent
11 minutes ago
- The Independent
Trump threatens India with 50% tariffs for buying Russian oil
U.S. President Donald Trump 's had signed an executive order subjecting Indian imports to a 50% tariff due to its purchase of Russian oil. The order subjects Indian imports to an additional 25% in duties on top of an existing 25% tariff. Indian Prime Minister Narendra Modi has been urged by India's opposition parties and the general public to stand up to Trump, labelling the move as 'bullying'. Trump has been warned his latest tirade threatens to undo two decades of diplomatic progress, analysts and officials say, and could derail other areas of cooperation as domestic political pressures drive both sides to harden their stances. While India has emerged in recent years as a key partner for Washington in its strategic rivalry with China, its large U.S. trade surplus and close relations with Russia – which Trump is seeking to pressure into agreeing to a peace agreement with Ukraine – have made it a prime target in the Republican president's global tariff offensive. Trump's taunt that India could buy oil from arch enemy Pakistan has also not gone down well in New Delhi, said two Indian government sources. India has also rejected repeated claims by Trump that he used trade as a lever to end a recent military conflict between India and Pakistan. In an unusually sharp statement this week, India accused the U.S. of double standards in singling it out for Russian oil imports while continuing to buy Russian uranium hexafluoride, palladium and fertiliser. On Wednesday, it called the tariffs "unfair, unjustified and unreasonable," vowing to "take all actions necessary to protect its national interests." But New Delhi knows that any further escalation will hurt it in matters beyond trade, said the sources. Unlike China, India does not have leverage like supplies of rare earths to force Trump's hand to improve the terms of any trade deal, they said. In recent years, successive U.S. administrations, including Trump's first, carefully cultivated relations with India with an eye on it as a vital partner in long-term efforts to counter the growing might of China. But analysts say Trump's recent moves have plunged the relationship back to possibly its worst phase since the U.S. imposed sanctions on India for nuclear tests in 1998. "India is now in a trap: because of Trump's pressure, Modi will reduce India's oil purchases from Russia, but he cannot publicly admit to doing so for fear of looking like he's surrendering to Trump's blackmail," said Ashley Tellis at Washington's Carnegie Endowment for International Peace. "We could be heading into a needless crisis that unravels a quarter century of hard-won gains with India." Indian state refiners have in recent days stopped buying Russian oil as discounts narrowed and pressure from Trump rose, Reuters has reported. New challenges for relations A more pressing challenge for India, analysts say, is the stark divergence between its priorities and Trump's political base on key issues such as work visas for tech professionals and offshoring of services. India has long been a major beneficiary of U.S. work visa programs and the outsourcing of software and business services, a sore point for Americans who have lost jobs to cheaper workers in India. Relations with India risk becoming a "football in American domestic politics," warned Evan Feigenbaum, a former senior State Department official under the Republican presidency of George W. Bush. "Issues that directly touch India are among the most partisan and explosive in Washington, including immigration and deportation, H1B visas for tech workers, offshoring and overseas manufacturing by U.S. companies, and technology sharing and co-innovation with foreigners," he wrote in a LinkedIn post. Since a 2008 deal to cooperate on civilian nuclear technology, the two countries have deepened intelligence sharing and defence cooperation and expanded interactions with Australia and Japan through the Quad grouping aimed at containing China's dominance in the Indo-Pacific. But fractures have appeared, despite Modi's rapport with Trump in his first term and then former President Joe Biden. Images in February of Indians deported by the U.S. on military planes, their hands and legs shackled, horrified the country just days before Modi went to see Trump seeking to stave off high tariffs. The relationship was also seriously tested in late 2023 when the U.S. said it had foiled a plot with Indian links to kill a Sikh separatist leader on U.S. soil. New Delhi has denied any official connection to the plot. "The Modi regime's credibility in the U.S. has gone down," said Sukh Deo Muni, a former Indian diplomat and a professor emeritus at New Delhi's Jawaharlal Nehru University. "And maybe there are people who think that India or Modi had to be brought back on track, if not taught a lesson. And if that trend continues, I'm quite worried that the challenge is quite powerful and strong for India to navigate." Strengthening ties with US rivals One Indian government source said India needs to gradually repair ties with the U.S. while engaging more with other nations that have faced the brunt of Trump tariffs and aid cuts, including the African Union and the BRICS bloc that includes Brazil, Russia, China and South Africa. India is already making some moves with Russia and China. Russian President Vladimir Putin is expected to visit New Delhi this year and on Tuesday, Russia said the two countries had discussed further strengthening defence cooperation "in the form of a particularly privileged strategic partnership." India has also boosted engagement with China, a change after years of tensions following a deadly border clash in 2020. Modi is set to visit China soon for the first time since 2018. "Russia will attempt to exploit the rift between the U.S. and India by proposing the restoration of the Russia-India-China trilateral and new projects in defence," said analyst Aleksei Zakharov at the Observer Research Foundation in New Delhi.
